Tekla Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-31,652
| Closed | -$784K | – | 175 |
|
|
2022
Q2 | $784K | Hold |
31,652
| – | – | 0.03% | 139 |
|
|
2022
Q1 | $1.23M | Sell |
31,652
-41,075
| -56% | -$1.59M | 0.04% | 139 |
|
|
2021
Q4 | $4.26M | Hold |
72,727
| – | – | 0.14% | 104 |
|
|
2021
Q3 | $4.31M | Hold |
72,727
| – | – | 0.14% | 112 |
|
|
2021
Q2 | $6.31M | Sell |
72,727
-77,616
| -52% | -$6.74M | 0.21% | 108 |
|
|
2021
Q1 | $12.4M | Sell |
150,343
-15,974
| -10% | -$1.32M | 0.43% | 62 |
|
|
2020
Q4 | $15.1M | Sell |
166,317
-51,145
| -24% | -$4.65M | 0.53% | 55 |
|
|
2020
Q3 | $8.69M | Buy |
217,462
+31,790
| +17% | +$1.27M | 0.33% | 74 |
|
|
2020
Q2 | $6.37M | Buy |
185,672
+20,000
| +12% | +$686K | 0.24% | 85 |
|
|
2020
Q1 | $3.68M | Hold |
165,672
| – | – | 0.17% | 103 |
|
|
2019
Q4 | $3.24M | Hold |
165,672
| – | – | 0.12% | 133 |
|
|
2019
Q3 | $2.57M | Buy |
165,672
+141,293
| +580% | +$2.19M | 0.11% | 121 |
|
|
2019
Q2 | $495K | Buy |
+24,379
| New | +$495K | 0.02% | 184 |
|